Back to companies
Humane Genomics
Seed / Series Adefense-other · Seed
Seed Signal Score
10/25
Team Strength
2/5
Validation Depth
2/5
Novelty
3/5
Market Timing
1/5
Capital Efficiency
2/5
Description
A platform to make artificial viruses as cancer therapeutics.
Validation Signals
yc batch
Score Rationale
Humane Genomics appears to be a biotech company focused on viral cancer therapeutics—a legitimate field but with minimal credible defense application. YC participation alone does not validate defense-sector fit; the company lacks named founders, any government contract or pilot evidence, and no clear connection to DoD priorities. The novelty (engineered viral therapeutics) is real in oncology but represents a crowded space dominated by established biotech firms, and the 'defense-other' categorization appears speculative without visible military/national security use cases.